PLK1 inhibitor

Advertisement

cGxPJobs Banner

Cardiff Oncology Showcases Promising Phase 2 Onvansertib Results Ahead of ASCO 2026

SAN DIEGO, Calif., May 21, 2026 Cardiff Oncology, Inc. announced that updated data from its ongoing Phase 2 CRDF-004...

By cGxPwire Editor
May 22, 2026

Read More

Cardiff Oncology Onvansertib mCRC Data at ASCO 2026

SAN DIEGO, Calif., April 21, 2026 Cardiff Oncology, Inc. announced it will present updated Phase 2 data for its...

By cGxPwire Editor
April 22, 2026

Read More

Advertisement

cGxPJobs

Directory